US Patent Issued to LinXis on Feb. 17 for "Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation" (Dutch Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,866, issued on Feb. 17, was assigned to LinXis B.V. (Amsterdam).

"Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation" was invented by Hendrik Jan Houthoff (Amsterdam), Paulus Martinus Petrus van Bergen en Henegouwen (Utrecht, Netherlands), Niels Jurriaan Sijbrandi (Utrecht, Netherlands), Joey Armand Muns (Hoofddorp, Netherlands), Jan Hendrik Schooten (Utrecht, Netherlands) and Sebas Daniel Pronk (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of binding molecules comprising at least one single variable antibody domain, targeted at recep...